Skip to main content

Advertisement

Log in

Effect of Sanguisorba minor on scopolamine-induced memory loss in rat: involvement of oxidative stress and acetylcholinesterase

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Sanguisorba minor (S. minor) has neuroprotective and antioxidant activities. However, its potential benefits in ameliorating learning and memory functions have been explored in no studies up to now. So, in the current study, rats were treated with S. minor hydro-ethanolic extract (50, 100, and 200 mg/kg, intraperitoneal (i.p.)) as well as rivastigmine (0.5 mg/kg, i.p.) for 21 consecutive days. Thereafter, their behavioral performance was assessed using Morris water maze (MWM) and passive avoidance (PA) tasks. Notably, 30 min before conducting the tasks, scopolamine was injected. Finally, the biochemical assessments were done using the brain tissue. The extract characterization was performed by liquid chromatography-mass spectrometry, which confirmed the presence of quercetin, myricetin, kaempferol, catechin, ellagic acid, and gallic acid derivatives. In the MWM test, the extract reduced both escape latency and the travelled distance, compared to the scopolamine group. Moreover, in the PA test, the latency to enter the dark chamber significantly increased by the extract, compared to the scopolamine group (p < 0.05-p < 0.001). Notably, the beneficial effects of S. minor on cognitive performance of the scopolamine-treated rats appeared to be similar or even better than rivastigmine in behavior performance. Similar to rivastigmine, it was observed that the extract attenuated both AChE activity and oxidative injury in the brain as evidenced by the increased antioxidant enzymes and total thiol content; however, it decreased malondialdehyde level (p < 0.05-p < 0.001). In conclusion, the results suggested the effectiveness of S. minor in preventing cognitive dysfunction induced by scopolamine. Accordingly, these protective effects might be produced by the regulation of cholinergic activity and oxidative stress. S. minor could be considered as a potential alternative therapy in cognition disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

The authors confirm that all data generated or analyzed during this study are included in this published article.

References

Download references

Acknowledgments

This paper was financially supported by Vice Chancellor for Research and Technology (grant number 980349), Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

This study was funded by Vice Chancellor for Research and Technology, Mashhad University of Medical Sciences with the following grant number: 980349.

Author information

Authors and Affiliations

Authors

Contributions

Arezoo Rajabian and Mahmoud Hosseini conducted conception and design of the project. Zeinab Hosseini, Fatemeh Mansouritorghabeh, Faezeh Sadat Hosseini Kakhki, and Arezoo Rajabian performed the experiments. Arezoo Rajabian and Mahmoud Hosseini performed statistical analysis and wrote the manuscript. Hassan Rakhshandeh, Maede Hasanpour, Mehrdad Iranshahi, and Azar Hosseini provided the plant and LC-Ms analysis. All authors contributed to manuscript preparation and approved the submitted version.

Corresponding author

Correspondence to Arezoo Rajabian.

Ethics declarations

Ethical approval

All procedures performed in this study including animals were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by Ethical Committee of the Animal Research of Mashhad University of Medical Sciences (Ethical code: IR.MUMS.MEDICAL.REC.1398.655).

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Zeinab Hosseini and Fatemeh Mansouritorghabeh share the first co-authorship equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hosseini, Z., Mansouritorghabeh, F., Kakhki, F.S.H. et al. Effect of Sanguisorba minor on scopolamine-induced memory loss in rat: involvement of oxidative stress and acetylcholinesterase. Metab Brain Dis 37, 473–488 (2022). https://doi.org/10.1007/s11011-021-00898-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-021-00898-y

Keywords

Navigation